ABCC6 Heterozygosity as Genetic Predisposition to Cerebrovascular Disease Across Ages
Genes · 2026
DOI: 10.3390/genes17020226 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Genes, 2026. Verfasst von Giulia Amico und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Human Genetics, IRCCS Istituto Giannina Gaslini, Via Gerolamo Gaslini, 5, 16147 Genoa, Italy. Hauptthemen laut MEDLINE: ATP-Binding Cassette, Sub-Family C Proteins, Genetic Predisposition to Disease, Cerebrovascular Disorders, Cerebral Small Vessel Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Italian Ministry of Health, the “Compagnia di San Paolo”.
Abstract (Originalsprache)
Background
Heterozygosity for pathogenic variants in the ABCC6 gene has been associated with an increased incidence of cerebrovascular diseases. This study aims to characterize the prevalence and clinical and neuroradiological phenotypes associated with monoallelic and biallelic ABCC6 variants in pediatric and adult patients presenting with arterial ischemic stroke or cerebral small vessel disease (CSVD).
Methods
We conducted a retrospective observational study on 143 consecutive patients (48 pediatric, 24 juvenile, 71 adult) diagnosed with ischemic stroke or CSVD of unknown etiology. Clinical and neuroradiological data were collected and analyzed in relation to the identified genetic variants through next-generation sequencing.
Results
Among the patients, 16 (11.2%) tested positive for causative variants in the ABCC6 gene, with 11 subjects carrying monoallelic variants and 5 carrying biallelic variants. Patients with biallelic variants exhibited severe and complex vasculopathy, with a high incidence of early ischemic events. In contrast, monoallelic carriers predominantly presented with microvascular disease manifestations, including lacunar strokes and signs of CSVD.
Conclusions
The results suggest a significant age-dependent phenotypic divergence in patients with ABCC6 variants, highlighting the impact of heterozygosity on cerebrovascular health. Identifying these variants may enhance risk stratification and inform management strategies in patients with traditional vascular risk factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Human Genetics, IRCCS Istituto Giannina Gaslini, Via Gerolamo Gaslini, 5, 16147 Genoa, Italy.
- Gaslini Stroke Study Group.
- Neuroradiology Unit, IRCCS Istituto Giannina Gaslini, Via Gerolamo Gaslini, 5, 16147 Genoa, Italy.
- Physical Medicine and Rehabilitation Unit, IRCCS Istituto Giannina Gaslini, Via Gerolamo Gaslini, 5, 16147 Genoa, Italy.
- Neuroradiology Unit, Ospedale Santa Maria della Misericordia, AULSS5 Polesana, 45100 Rovigo, Italy.
- Rare Diseases Unit, IRCCS Istituto Giannina Gaslini, Via Gerolamo Gaslini, 5, 16147 Genoa, Italy.
ORCID-Profile: Giulia Amico, Marta Bertamino, Rosario Pascarella, Domenico Tortora, Marta Rusmini, Andrea Rossi, Isabella Ceccherini, Marialuisa Zedde
Förderung
- the Italian Ministry of Health
- the “Compagnia di San Paolo”
Zitieren
APA
Amico, G., Severino, M., Bertamino, M., Pascarella, R., Tortora, D., Signa, S., Rusmini, M., Rossi, A., Ceccherini, I., & Zedde, M. (2026). ABCC6 Heterozygosity as Genetic Predisposition to Cerebrovascular Disease Across Ages. Genes. https://doi.org/10.3390/genes17020226
Vancouver
Amico G, Severino M, Bertamino M, Pascarella R, Tortora D, Signa S, et al. ABCC6 Heterozygosity as Genetic Predisposition to Cerebrovascular Disease Across Ages. Genes. 2026. doi:10.3390/genes17020226
BibTeX
@article{Amico2026,
author = {Amico, Giulia and Severino, Mariasavina and Bertamino, Marta and Pascarella, Rosario and Tortora, Domenico and Signa, Sara and Rusmini, Marta and Rossi, Andrea and Ceccherini, Isabella and Zedde, Marialuisa},
title = {ABCC6 Heterozygosity as Genetic Predisposition to Cerebrovascular Disease Across Ages},
journal = {Genes},
year = {2026},
doi = {10.3390/genes17020226}
}
EUVIMED